Tag: FDA exclusivity

• Cassius Thornfield
• 0

The 180-day exclusivity rule under the Hatch-Waxman Act gives the first generic drug challenger a temporary monopoly to incentivize patent challenges-but it often delays market entry for years, keeping prices high. Here's how it works and why it matters.